European journal of cancer (Oxford, England : 1990), Vol. 164, p. 39-51 (2022) European journal of cancer 2022, ' Serum thymidine kinase activity in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with palbociclib and fulvestrant ', European Journal of Cancer, vol. 164, pp. 39-51 . https://doi.org/10.1016/j.ejca.2021.12.030
European journal of cancer (Oxford, England : 1990), Vol. 166, no. 1, p. 300-308 (2022) European Journal of Cancer European Journal of Cancer, 2022, 166, pp.300-308. ⟨10.1016/j.ejca.2022.01.014⟩